Corresponding Author: Don L. Goldenberg,
MD, Department of Rheumatology, Newton-Wellesley Hospital, 2000 Washington
St, Newton, MA 02462 (dgoldenb@massmed.org).
Funding/Support: This study was sponsored by
the American Pain Society.
Role of the Sponsor: The American Pain Society
did not participate in the design and conduct of the study, in the collection,
analysis, and interpretation of the data, or in the preparation, review, or
approval of the manuscript.
Acknowledgment: We thank the other members
of the American Pain Society Fibromyalgia Panel: Robert Gerwin, MD, Department
of Neurology, The Johns Hopkins Hospital, Baltimore, Md; Sue Gowans, PhD,
PT, University Health Network Toronto General Hospital, Department of Rehabilitation
Services, Toronto, Ontario, Canada; Kenneth C. Jackson II, PharmD, Practice-Pain
Management, Texas Tech University Health Sciences Center at Amarillo, School
of Pharmacy, Lubbock; Pearl Kugel, BBA, San Diego, Calif; William McCarberg,
MD, Chronic Pain Management Program, Kaiser Permanente, Escondido, Calif;
Nathan J. Rudin, MD, Department of Orthopedics and Rehabilitation, University
of Wisconsin Medical School, Madison; Laura Schanberg, MD, Pediatric Rheumatology
Division, Duke University Medical Center, Durham, NC; Ann G. Taylor, RN, EdD,
Betty Norman Norris Professor of Nursing, Center for the Study of Complementary
and Alternative Therapies, University of Virginia Health System, Charlottesville;
Janalee Taylor, MS, RN, Clinical Nurse Specialist, Children’s Hospital
Medical Center, Cincinnati, Ohio; and Dennis C. Turk, PhD, Department of Anesthesiology,
University of Washington, Seattle. We also thank staff members of the American
Pain Society and especially Ada Jacox, PhD, RN, and Carol D. Spengler, PhD,
RN, APS Clinical Practice Guidelines Program, University of Virginia School
of Nursing, Charlottesville; and the many reviewers and staff who worked on
the APS fibromyalgia syndrome document.